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Abstract
Background: A number of protected learning time schemes have been set up in primary care
across the United Kingdom but there has been little published evidence of their impact on
processes of care. We undertook a qualitative study to investigate the perceptions of practitioners
involved in a specific educational intervention in diabetes as part of a protected learning time
scheme for primary health care teams, relating to changing processes of diabetes care in general
practice.
Methods: We undertook semistructured interviews of key informants from a sample of practices
stratified according to the extent they had changed behaviour in prescribing of ramipril and diabetes
care more generally, following a specific educational intervention in Lincolnshire, United Kingdom.
Interviews sought information on facilitators and barriers to change in organisational behaviour for
the care of diabetes.
Results: An interprofessional protected learning time scheme event was perceived by some but
not all participants as bringing about changes in processes for diabetes care. Participants cited
examples of change introduced partly as a result of the educational session. This included using ACE
inhibitors as first line for patients with diabetes who developed hypertension, increased use of
aspirin, switching patients to glitazones, and conversion to insulin either directly or by referral to
secondary care. Other reported factors for change, unrelated to the educational intervention,
included financially driven performance targets, research evidence and national guidance.
Facilitators for change linked to the educational session were peer support and teamworking
supported by audit and comparative feedback.
Conclusion: This study has shown how a protected learning time scheme, using interprofessional
learning, local opinion leaders and early implementers as change agents may have influenced
changes in systems of diabetes care in selected practices but also how other confounding factors
played an important part in changes that occurred in practice.
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A number of protected learning time (PLT) schemes in
primary care have been set up across the United Kingdom.
Published evaluations have focused on organisational
aspects and the views of participants of the benefits, prob-
lems and possible effects of such schemes [1-6]. There has
been little published evidence of their impact on proc-
esses of care or improved patient outcomes. Reported
effects on prescribing behaviour or process changes have
not adequately accounted for secular (underlying) trends
in performance.
It has been argued that studies of educational interven-
tions should evaluate change in a geographical area
(rather than a single practice) targeting an identifiable
learning need which if addressed could lead to real
improvements in patient outcomes [7]. In the case of
interprofessional learning, "when [members or students
of] two or more professions learn with, from and about
one another to improve collaboration and the quality of
care [8]" it should also be focused on a relevant problem
appropriate for the multiprofessional group [4]. In order
to do this a mixed methods study was conducted into the
effect on practice prescribing and behaviour of an educa-
tional session on diabetes care provided by Lincolnshire
TARGET (Time for Audit, Review, Guidelines, Education
and Training), set up as an multidisciplinary protected
learning time (PLT) scheme, and innovative in that it
involved all general practices with their associated pri-
mary care teams in a large rural county of the East Mid-
lands, United Kingdom.
The educational session was centred around the HOPE
study which provided evidence that patients with coexist-
ing diabetes and hypertension or other cardiovascular risk
factors should be treated with an ACE inhibitor at a ther-
apeutic dose (specifically ramipril 10 mg) [9] to reduce
cardiovascular morbidity and mortality. An interrupted
time series analysis showed a significant increase in ACE
inhibitor prescribing across the county, taking into
account secular change, following the educational inter-
vention (odds ratio 1.50, 95% CI 1.07–1.93) with an
increase in prescribing of ramipril by 52,345 items
(31,132 items at 10 mg) at a cost of £292 k to £460 k
depending on formulation [10].
The aim of this parallel qualitative study was to investigate
the perceptions of practitioners on the effect of the educa-
tional event relating to their processes of diabetes care. We
were interested in what practices did, if anything, to
implement and sustain change as a result of the educa-
tional intervention, what the barriers to change were,
what other external factors may have led to change, and
which elements of the educational intervention were
helpful or not helpful.
Methods
Lincolnshire TARGET
Lincolnshire TARGET was set up in 2000 with the aim of
providing needs based learning for general practitioners,
community nurses and administrative staff working in
primary care during working hours. This was achieved by
using local out-of-hours cooperatives and other internal
arrangements in group practices to provide primary care
services during educational sessions. Each session was
organised and delivered by a team of educators, led by a
clinical director with administrative support, and focused
on a topic based on both local practitioner need and
national priorities. The sessions involved a combination
of lectures delivered by local, regional or national opinion
leaders and facilitated small interdisciplinary group work
involving medical, nursing and administrative staff. At the
end of each session individual primary care teams worked
in small groups to discuss how they might implement
change as a result of the education. TARGET included edu-
cational sponsorship from a number of pharmaceutical
companies and promotional stands were also a feature of
the sessions. Lunch was provided before the educational
meeting began but no other incentives were offered to
encourage attendance.
Intervention of interest
The educational session on diabetes was delivered in
November 2001 and lasted about 2.5 hours. It consisted
of a welcome session outlining the objectives for the after-
noon, an opening talk to set the scene of diabetes in gen-
eral practice followed by parallel talks for clinicians and
administrative staff. The first session for clinicians was
designed to look at diabetes prevalence and screening fol-
lowing which a local general practitioner who had suc-
cessfully implemented the findings from HOPE into his
own practice was able to describe practical steps leading to
improvements in ACE inhibitor prescribing for diabetes
within his practice.
For other (including nonclinical) staff a talk was given
from the patient's perspective by a speaker from Diabetes
UK, a talk on the diabetic clinic was given by a local spe-
cialist diabetic nurse and a practical session looking at
computer data, risk assessment and routine procedures,
for example in reception, was given. Finally practices
teams met together as a group, to discuss the barriers to
improving practice processes for diabetes care, including
implementation of HOPE, and considered an action plan
of how they might overcome barriers and implement bet-
ter systems of care. Each plan was fed back to the whole
audience.
Selection and interviews
Interviewees were chosen purposively from selected prac-
tices. Nurses and general practitioners providing diabetesPage 2 of 9
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were more likely to have in-depth knowledge of changes
in processes of care whether related to the intervention or
not. Practices were selected according to the extent of
change in prescribing following the educational interven-
tion. Stratified sampling was used to get a variety of per-
spectives because the quantitative study showed that there
were differences in change in prescribing rates in practices
in temporal relation to the intervention. Practices were
therefore divided into four strata depending on change in
prescribing as follows [10]:
Stratum 1 (S1): little increase in prescribing before or after
the educational intervention
Stratum 2 (S2): some increase in prescribing before and
after
Stratum 3 (S3): little change before but a great deal after
Stratum 4 (S4): a great deal of change before and after
One of the authors (KS) selected three practices, ordered
at random, from each of the four strata and invited them
to take part in the qualitative interview study. If a practice
declined to take part the next practice on the list from that
stratum was invited. A total of twelve interviews were car-
ried out, three from each of the four strata. Interviewees
(practices) and interviewers were blinded to the practice
stratum so that neither the practice, nor the interviewers
were aware of the stratum from which the practice was
drawn at the time of the interview (see Table 1). The audi-
otape from one practice in stratum 2 was inadvertently
damaged precluding analysis. Informed consent was
sought from participants.
Interviews and data analysis
The interviews looked for perceptions of change in diabe-
tes care and facilitators of change. This included not only
the educational session but also any other factors that may
have prompted change, barriers to change and evidence of
practice interventions to implement change (Table 2).
One-to-one in depth interviews took place at the practice
premises in 2003, within 18 months of the educational
session. They were 45 to 90 minutes in duration and con-
ducted individually by two researchers. They were tape
recorded and transcribed in full. Qualitative data from the
transcripts were analysed using specific software (QSR
N6). A sample of the transcripts was independently exam-
ined by all members of the project team and categories
derived by induction. Categories were decided and
grouped into themes through discussion. Themes were
identified in the context of the stratum and the profes-
sional discipline of the interviewee and agreed through
examination of transcripts by all members of the team.
Thematic analysis was used to make sense of the data. This
involved examining the transcribed interviews to identify
key issues and then coding and categorising text express-
ing these recurrent issues to form explanatory themes.
Ethics committee
Lincolnshire Research Ethics Committee (study number:
02/1/680). The study was approved for research manage-
ment and governance by West Lincolnshire PCT.
Results
101 practices, 38 from East Lincolnshire, 25 from Lincoln-
shire South, and 38 from West Lincolnshire were included
in the study. Of these, 15 were training practices, 56 Per-
sonal Medical Services (PMS), 18 single-handed practices
and 59 dispensing. At least one GP attended the interven-
tion session from 68 practices, and from 64 at least one
practice nurse or health visitor attended. No clinical pro-
Table 1: Characteristics of participating practices
Stratum Stratum 1: little increase 
before or after0 
(n = 50; non consenting 2)
Stratum 2: some increase 
before or after 
(n = 27; non consenting 23)
Stratum 3: little increase 
before, lots after 
(n = 12, non consenting 4)
Stratum 4: great increase 
before and after 
(n = 14, non consenting 5)
Interviewed practices (n = 
11)
3 2 3 3
Characteristics: of interviewees 
and interviewed practices
a. GP, semirural, 5 partner 
ELPCT
a. GP, urban, 3 partner, WLPCT a. Nurse, semirural, 4 partner 
WLPCT
a. GP, semirural, 9 partner 
training WLPCT
b. GP, semirural, single handed 
ELPCT
b. GP, rural 4 partner ELPCT b. Nurse, rural, 6 partner 
ELPCT
b. GP, semirural, 4 partner 
ELPCT
c. GP, urban, 3 partner WLPCT c. GP, urban, 8 partner, training, 
LSWPCT
c. GP, rural, 6 partner ELPCT
All practices (n = 103)
Single handed (n = 20) 16 3 0 0
Dispensing (n = 59) 26 12 9 12
Training (n = 15) 4 6 2 3
At least one GP attending (n = 
68)
25 24 8 11
At least one PN/HV attending 28 20 8 8Page 3 of 9
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tices only one or more GPs attended and no nurses, from
8 practices one or more practice nurses or health visitors
but no GPs, and from 56 at least one GP and at least one
practice nurse or health visitor attended. All 101 practices
had their prescribing data analysed for ACE inhibitor pre-
scribing before and after the educational session and the
quantitative analysis has been described in detail in a sep-
arate paper [10].
The results have been written under the five main themes
emerging from the data which include changes in proc-
esses of care, facilitators for change, barriers to change,
sustaining change and perceived effect of PLT (See Table
3). In order to differentiate between the different strata
and also the professional group of the interviewee, each
quote was identified as such, for example stratum one, GP
quote (S1 GP), or stratum three nurse (S3 NS). The effect
of stratum on change was also explored.
Changes in processes of care
The main changes stated by interviewees in the care of
patients with diabetes in the year following the educa-
tional intervention included increased used of protocols
and policies; using ACE inhibitors as a first line for
patients with diabetes who developed hypertension;
switching patients to glitazones; increased use of aspirin
and statins; putting patients on insulin either directly or
by referral to secondary care; quicker titration of drugs
leading to increased prescriptions; increased screening
and review of patients with diabetes. Practices in strata 1
and 2, though still aspiring to improve care were less able
to specify the precise interventions by which they did this.
Protocol development
"...We've had a diabetes protocol in existence for about 4 or 5
years...it's now in its third different edition...because we did the
'Micro-Hope' and NSF as a single editing and its now been
redone for the Quality and Outcomes Framework..." (S4 GP)
Policy review
"Well we've reviewed the policy of putting all the hypertensive
patients on ACE inhibitors ... and ACE inhibitors as a first line
for all diabetic patients who turned hypertensive after they
developed diabetes." (S4 GP)
Increased review leading to additional prescribing "We're see-
ing diabetic patients much more regularly than we did, and
we're noticing changes in their blood pressure and cholesterol
levels, making sure they have more screenings and all their
checks are in place." (S1 GP)
Table 2: Semistructured interview schedule
1. What have been the major changes in your management of patients with diabetes in your practice in the past two years?
2. What in your opinion were the factors that led to change your management of patients with diabetes in your practice in the past one to two 
years?
3. In your opinion, how did the TARGET meeting on diabetes affect how you managed patients with diabetes in your practice?
4. Did you make any changes as a direct result of the TARGET meeting?
5. What were these changes?
6. If it did lead to change, what features of the TARGET meeting do you believe enabled this change?
7. What other factors do you believe (may have) led to change in your practice?
8. What do you feel were possible barriers to this change and how important were they in preventing change?
9. How, if at all, did you seek to overcome these barriers?
10. How have you managed to sustain change?
Table 3: Themes and subthemes
Changes in processes of care
Protocol development
Policy review





Information technology and decision support
Role redesign
Training in diabetes




Risks versus benefits of medication
Lack of secondary care support
Sustaining change
Systematic attention to detail
Team approach/holistic care
Personal interest and enthusiasm
Perceived effect of TARGET on diabetes care
Specific changes made as result of TARGET attendance
Peer pressure in TARGET
Lack of change from TARGET
Use of consultants in TARGETPage 4 of 9
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"...We are using more glitazones than we were and having
some very good results..." (S3 NS)
"... [We] put most of the diabetic patients on aspirin, the
majority of them on a statin regardless of their cholesterol
level." (S3 NS)
"...We just referred the tenth patient to the nurse [for insulin],
those ten patients otherwise would have been referred to hospi-
tal." (S4 GP)
"We've picked up a lot of new diabetics, simply by the recall sys-
tem we have for our CHD patients and a lot of them are turning
up..."(S1 GP)
"...If you come in for a blood test you tend to get a glucose done
and it ifs high we then take it further we don't just think its
slightly high, you know, watch your diet, we do tend to do a
diagnostic for a blood glucose test." (S3 NS)
Facilitators for change
There were a number of explanatory factors offered by par-
ticipants as leading to these changes in diabetic care.
These ranged from dissatisfaction with current services to
government initiatives based on the outcomes of major
research studies. The main reported facilitators of change
were financially driven performance targets, particularly
those set by the new GP contract and quality and out-
comes framework, large research studies such as HOPE/
Micro HOPE, and UKPDS as well as government guide-
lines as outlined in the NICE guidance and Diabetes NSF.
Incentives and resources
"We can now use the stream of resources coming in that are
tied to quality, to employ people and health care assistants" (S4
GP)
"What's happened with the new contract is that you have been
given a financial incentive to do it, to record it and to make it
available for auditing and for PCTs to make sure you have done
it..." (S2 GP)
Evidence and guidance
"We decided as a practice after the publication of 'HOPE' that
we would take an opportunistic approach to starting diabetic
patients on ramipril when we saw them and that's been reason-
ably successful in bringing our rates of ramipril prescription
up.... "(S4 GP)
"UKPDS was such a huge trial...so you couldn't miss it unless
you were blind...it's not that they were telling you something
new but it does have an input." (S1 GP)
"And of course all the NICE guidance that came out, particu-
larly with the use of diabetes zones, the drug therapies, foot care
guidance that was out in January, that's influenced the way we
refer to podiatry and how the podiatry work with us now." (S3
NS)
"Evidence from the National Service Framework...NICE and
clinical guidelines... so probably all those things, the most
important would probably be the NSF I would think." (S2 GP)
Information sources
Information was received from a number of sources
including the Primary Care Organisations and profes-
sional journals but drug representatives were also seen as
an important source of information.
"The National Service Framework regarding diabetes and pro-
tocols that have come in from the Trust." (S2 GP)
"Well I take a couple of these diabetes and CHD combined
journals...and then if it's of particular interest to me or partic-
ularly pertinent to a patient then I might look it up." (S3 NS)
"I think they [drug representatives] probably played a bit more
of a part here that they usually let them do which is that they
did persuade me that glitazones were probably a good thing..."
(S4 GP)
Clinical audit
Audit and benchmarking care against other practices' per-
formance was perceived to be an important driver for
change in all practices interviewed. Clinicians in most
practices used 'real-time' entry to improve data recording
but for some practices this was a relatively recent phenom-
enon.
"...We've taken a sample of about 50–60 patients we've picked
up at random and we've followed them right the way through
and it's a report back but a lot of things have changed over those
two years so its quite interesting." (S3 NS)
"You're in line with your colleagues and thinking along the
same line I think sort of group approach... everybody's calling
the same tune, at least within this county." (S1 GP)
Information technology and decision support
"We're all using the computer live and we've being doing so for
quite a while, it's take a bit of a churn to get people to do it but
it's working." (S1 GP)
"We've got a very slight detailed template...we've got extra
things on that we like and we also have sub templates for podi-
atry and eye screening retinopathy..." (S3 NS)Page 5 of 9
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A number of practices encouraged nurses, particularly the
diabetes nurse, to take a leading role in delivery. Health
care assistants also supported diabetes care, either work-
ing alongside the nurse or to protocols supervised by the
general practitioner (GP). GPs appreciated that using
health care assistants in this way was a radical change.
" [We are] encouraging the nurse practitioner to take on more
of a leading role..." (S1 GP)
"Our diabetic nurse...we do tap into her, her sources and her
skills, and if we have something difficult we will turn to her
rather than a hospital clinic...""the health care assistants do the
blood tests,...height,...weight, the blood pressure, they check
that they're seeing the chiropodist, ... the opticians and they fill
in as much as they can." (S3 GP)
Training in diabetes
Training of professionals in the care of diabetes was also
seen as a facilitator of change. By contrast one practice in
stratum 1 felt that he was under too much other pressure
to consider training in diabetes.
"I think everybody who sees a diabetic patient should have had
some training, you know, not just the minimum, hide behind
the one day, diabetes management course its got to be some-
thing much more encompassing the complexities of the dis-
ease." (S3 NS)
"I went to the diabetes UK conference two years ago and came
back from that really fired up, so the doctors have very much let
it be led by me..." (S3 SN)
Patient involvement and empowerment
Clinicians interviewed expressed ambivalence about
patient empowerment. Some clinicians felt that patients
were increasingly knowledgeable about their condition,
often using the Internet for information, and this affected
how they provided services.
Giving patients written information about their condition
was seen as empowering. Some practices offered routine
annual reviews whilst others actively encouraged patients
to decide when to contact the practice for additional care
or advice. Patient held records were also mentioned by
one practice that felt that they helped inform patients
about what had been done for them.
"I was looking at ways in which to empower the patients and
what that empowerment actually meant to people. What we
actually discovered was, empowerment meant different things
to different people." (S1 GP)
"A lot of patients would really we 'did' it for them.... I'm afraid
I'm a bit sceptical about patient empowerment, I think there are
patients who do but I'm not sure that it's as quite as wide
spread...as the enthusiasts for it would have you believe." (S4
GP)
"What we do is send off a pack with various nutrition informa-
tion...that sort of stuff, together with their annual blood forms
and things like that so that when they come back we then invite
them back to the clinic." (S1 GP)
"Because we only recall our patients once a year with having so
many we rely on them doing the blood test and coming in if
there's a change and telling us, I mean that again is patient
education but we spend a lot time sort of explaining that if
there's a big change...don't wait..."(S3 GP)
Barriers to change
Inertia was cited as a hurdle to change. One of these prac-
tices had undergone significant change already, the other
less so. Other stated barriers included resources, concerns
over doing more harm than good with medication and
lack of secondary care support.
Inertia
"I think that partly it's the inertia in the system that when
you're doing things and the results show you that you're doing
pretty well there's a tendency to say, well fine, don't need to put
much more effort into changing things here..." (S4 GP)
"The most difficult thing is to then make the change... going
back and deciding how we going to get better, making sure eve-
ryone knows about it and discussing it and finding the time to
go over it. I think we've done okay." (S2 GP)
Lack of resources
"I work twenty-six hours a week and I could spend every hour
of that doing diabetics, I don't because I'm a nurse practitioner
as well and with us being short-staffed at the moment..." (S3
NS)
"Time ... diabetes is not the only thing to get done, so it is the
practice staff time." (S1 GP)
"Financial, lots of space and more opportunity for education."
(S1 GP)
"Yes, there's two big barriers, one is time and one is money and
that's the two big things. I mean if we could fund more hours
for diabetic patients [although] we couldn't at the moment
because of the building space..." (S3 NS)Page 6 of 9
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One GP felt concern about putting patients who appeared
otherwise healthy onto an increasing number of poten-
tially harmful medications in order to meet targets.
"I've got somebody in their late seventies...who's had type 2 dia-
betes for decades I find it very difficult motivating myself to get
her cholesterol down. I find that very difficult to defend, and I
appreciate that somebody else might say that you shouldn't be
allowed to do that... Occasionally I think why am I making this
woman potentially ill with medication...blood pressure reduc-
tion can be achieved ultimately but it may take four or five dif-
ferent approaches per patient and we have to ask ourselves, is
that in the patient's best interest and all these drugs?" (S2 GP)
Lack of secondary care support
"Dietician support ... at the moment it is pie in the sky, I think
its taking months and in fact the dietician have recently written
to us suggesting that because they're snowed under, we get our
practice nurses trained in what needs to be done for diabetic
assessment.... There's always more demand than supply." (S2
GP)
Sustaining change
Key factors in sustaining change were a systematic and
team based approach with enthusiastic clinicians who
had a personal interest in diabetes care.
Systematic attention to detail
"...getting into the habit so that when you see a patient coming
back for review you try and make it automatic, should they be
on an ACE inhibitor, do they need to be on a statin, is their
HBA1C still coming down or at least stable, so its really a ques-
tion of getting into habits of it which is why a diabetic clinic is
so advantageous because diabetes care more than anything else
I think is a matter of attention to detail." (S4 GP)
Team approach/holistic care
"I think it's the way you go about the change in the first
place...what we tend to do is take an idea to the team and let
them thrash it out and find out what the answers going to be."
(S3 NS)
"...by combining diabetes and care of its complications particu-
larly Coronary Heart Disease together we actually care for
patients fairly holistically, they don't on the whole go to the dia-
betic clinic and the Coronary Heart Disease clinic, we found
that we do them all in one go if we possibly can so that's time
saving..."(S4 GP)
Personal interest and enthusiasm
"It's the enthusiasm with which I carry something through that
becomes infectious and that's why the change, it's not all down
to me, it's like a domino effect." (S3 NS)
"I mean obviously it's been driven partially by the fact I have an
interest in diabetes anyway..." (S1 GP)
Perceived effect of TARGET on diabetes care
Participants expressed that the research outcomes of
major studies and government policy had a big impact on
practices. What difference did the protected learning time
session for diabetes make? Only one practice interviewed
stated that they had not attended TARGET. This GP was a
single-handed practitioner in stratum 1 and gave 'lack of
time' as his reason for non-attendance. Practices were
mixed in their opinions about whether TARGET had made
a difference in their care provision for patients with diabe-
tes. Although many felt that they were already implement-
ing change the majority of practices cited new systems
such as screening at-risk patients, providing information
for receptionists, organising foot care and putting patients
on aspirin as resulting directly from TARGET.
Group work was specifically mentioned as helpful by two
practices where working with 'fellow GPs', colleagues
from different disciplines and other practices was seen as
beneficial. Peer pressure and being seen to be 'in line' with
colleagues appeared to be another important factor. In-
house training using protected time was mentioned by
two practices in strata 3 and 4 as a way of developing their
individual practice's systems. Expert speakers (non GP)
had a limited appeal to some practitioners whereas other
general practitioners were welcomed.
Specific changes made as result of TARGET attendance
"Yes, that came from TARGET when we did the screening for
Diabetes, I remember being in the discussion about what's the
most economical way to detect the patients with undiagnosed
diabetes and as a consequence of that we target all our chronic
disease people for screening for diabetes..."(S3 NS)
"...the girls from the reception found it particularly useful meet-
ing people with diabetes and discussing the ins and outs, they
haven't been quite so aware of Hypos and blood tests and things
like that..."(S3 NS)
" [I] did go along to the TARGET morning that they had on foot
care in diabetes and that did modify my approach to examine
diabetic feet which has had a knock-on effect, we're pretty con-
fident about doing them so that they're now pulling out podiatry
for examining diabetic feet apart from more complicated
ones..."(S4 GP)
"Aspirin was one of the things that was brought up from the
TARGET meeting because we've been discussing it already
whether to put diabetics on aspirin and they did discuss the
HOPE study that really pushed along to decide that yes, we
were going to put people on aspirin, so yes that came directly out
of TARGET..." (S3 NS)Page 7 of 9
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"I did feel that there was like quite a big gap between people
who were doing their very best and the people who were not
doing very well at all." (S3 NS)
"If you're thinking of being more pro-active putting someone on
an inhibitor and you go along and every other GP says "Oh
yeah, that's a good idea, we're doing that", it will mean that
you do it, you get peer pressure to do it. If it was just one doctor
with a specialist interest [saying] by the way the latest research
shows this and all the GPs say 'yeah we'll do that next time."
(S2 GP)
Lack of change from TARGET
"It didn't make any difference here because we were already
doing most of what was done, ... the actual care in the practice
was already beyond what TARGET was aiming for anyway".
(S3 NS)
"No, because I didn't go to the meeting...I'm a single handed
practitioner and it's not as though I've got to travel a million
miles to target, but it's the time factor..."(S1 GP)
Use of consultants in TARGET
"...It's nice to see the consultant from time to time but it's best
practice in the situations that we find ourselves in and I think
there's a tendency to get a little tired with the experts telling
us..." (S4 GP)
Effect of stratum on change
Practices in strata 1 and 2 (little or some change before
and after the educational intervention) generally reported
making opportunistic rather than systematic improve-
ments whereas strata 3 and 4 practices (a great deal of
change before or after the educational intervention)
tended to cite influencing factors and resulting changes in
practice more often. Changes in processes were report to
occur in every practice to some extent, but for participants
from strata 3 and 4 described change at a faster pace. Prac-
tices in stratum 4 in particular tended to have been early
adopters, one practice in this group stating that they
started implementing 'HOPE' very soon after publication.
Practices in strata 3 & 4 were more likely to mention uti-
lising protected learning time for in-house training in
order to develop the practices' systems and teamworking.
Practices in strata 3 & 4 were also more likely to acknowl-
edge the benefit of diabetes education whereas those prac-
tices in stratum 1 reported themselves to be under too




Despite some interviewees reporting that protected learn-
ing time (PLT) had not been a major influence in bringing
about change in prescribing, others indicated that PLT was
one of a number of key drivers for bringing about change
in diabetes care in their practice [11]. Changes occurring
after the educational intervention included using ACE
inhibitors as a first line for patients with diabetes who
developed hypertension, increased use of aspirin, switch-
ing patients to glitazones and commencing insulin; such
changes by leading to better control of glucose and cardi-
ovascular risk factors are known to reduce complications
of diabetes.
Reported facilitators of change were financially driven
performance targets, research evidence and national guid-
ance. Despite many interviewees suggesting that they had
already looked at diabetes care provision and that the edu-
cational session may not necessarily have influenced this,
most practices offered explicit examples of change intro-
duced directly as a result of the session. Other factors for
change linked to the educational session were peer sup-
port, teamworking and benchmarking through audit and
comparative feedback.
Strengths and weaknesses
The main strengths of the study were that it provided an
explanatory framework for changes linked to a quantita-
tive study into the effect of protected learning time on pre-
scribing, that the practices were stratified for inclusion
according to change in prescribing and that prescribing
status was blinded by both interviewee and interviewer.
Limitations included the small number of practices from
each stratum and the potential for recall bias. Respondent
validation, or other data validation, was not undertaken.
Context of other literature
The findings support the role of peer influence and mod-
elling in the learning process [12] which was more than
simply from networking opportunities [2]. The protected
learning session provided influential sources of informa-
tion and delivered a personalised message, based on indi-
vidual experience focusing on specific evidence linked to
clear outcomes and encouraging change [13]. Local opin-
ion leaders and early adopters who contributed to the
educational programme may have had a beneficial effect
on adoption by others [14] and the interactive nature of
the educational process was more likely to improve out-
comes compared to didactic lectures [15], a view sup-
ported by adult educational theory [16]. Respondents
highlighted audit and benchmarking as facilitators for
change and although evidence for this from the literature
is equivocal [17] it could be argued that the audit process
was a mechanism for peer influence as well as providing a
basis for measurement of change. Interprofessional learn-
ing may also have had a positive impact [8] given that
members of practices teams had the opportunity to dis-
cuss potential changes during the session. This approachPage 8 of 9
(page number not for citation purposes)
BMC Medical Education 2008, 8:4 http://www.biomedcentral.com/1472-6920/8/4Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
was similar in some respects to the academic detailing
approach for practice teams [18].
Conclusion
This study has shown how a protected learning time
scheme, using local opinion leaders and early implement-
ers as change agents and audit and feedback, was one of a
number of factors supporting changing systems of diabe-
tes care in some practices. Utilising a combination of
approaches to address barriers to change [19] was integral
to the concept of the protected learning time scheme. The
educational session addressed barriers to change, known
to be helpful in modifying outcomes, by sharing learning
across practices [20]. Various other evidence based strate-
gies to improve performance, such as identifying with the
concerns of practitioners and patients, using practice-
based active learning methods, delivery by opinion lead-
ers and peers, encouraging collaboration and teamwork
were employed as part of the teaching programme [21].
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